Akorn Inc. (AKRX) Posts Q4 and FY 2010 Results; 2011 Guidance
Akorn Inc., a niche generic pharmaceutical company, today reported financial results for the fourth quarter and year ended December 31, 2010, noting key highlights and achievements that contributed to the results. Consolidated revenue for the fourth quarter of 2010 was $24.0 million, an increase of 32 percent over revenue of $18.2 million reported in the fourth quarter of last year. Fourth quarter 2010 core business revenue was $24.0 million, up 60 percent over the prior year quarter core revenue of $15.0 million. Consolidated revenue for the full-year 2010 was $86.4 million, up 14 percent over the full-year 2009 consolidated revenue…